Effect of Artificial Tears on Ocular Biometry Parameters
NCT06656403 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-10-24
Summary
Due to the instability of the tear film, the biometry often needs to be done multiple times in a clinical environment. The high variability of both short-term and long-term repeatability in keratometry of dry eyes is well-known. Consequently, enhancing the condition of the eye surface in individuals with dry eyes will result in improved precision when choosing the power of intraocular lenses (IOLs). This prospective and before-and-after self-control study will recruit 100 patients.
Conditions
- Dry Eye Disease
- Tear Film
Interventions
- DRUG
-
0.1% sodium hyaluronate
After baseline measurement, 0.1% sodium hyaluronate eye drops were instillation into the inferior conjunctival vault of both eyes
Sponsors & Collaborators
-
He Eye Hospital
lead OTHER
Principal Investigators
-
Guanghao Qin · He Eye Specialist Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-30
- Primary Completion
- 2024-11-20
- Completion
- 2024-11-21
More Related Trials
-
Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK
NCT06852105 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
NCT06655441 ·Status: RECRUITING ·Phase: PHASE4
-
Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes
NCT01363414 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation
NCT01128049 ·Status: COMPLETED ·Phase: NA
-
Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects
NCT01746602 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Tear Film Break-up Time After Instillation of Artificial Tears
NCT00681265 ·Status: COMPLETED ·Phase: NA
-
Impairment of Reading Ability in Dry Eye Patients
NCT01826812 ·Status: COMPLETED
-
Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease
NCT03888183 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Potential Role of Ocular Surface Microbiome in Dry Eye: Microbial Interactions and Symptom Alleviation
NCT06936462 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.
NCT06939959 ·Status: RECRUITING ·Phase: PHASE4
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT03211351 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy of Dry Eye (DE) Disease Treatment Using Novel Tear Film Imager (TFI)
NCT04670263 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye
NCT06537349 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation
NCT04633863 ·Status: COMPLETED ·Phase: NA
-
Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients
NCT05304637 ·Status: UNKNOWN ·Phase: PHASE4
-
0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation
NCT03000556 ·Status: UNKNOWN ·Phase: PHASE3
-
Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction
NCT02618304 ·Status: COMPLETED ·Phase: NA
-
Correlation of Different Signs for Assessment of Dry Eye Syndrome
NCT01753687 ·Status: COMPLETED ·Phase: NA
-
Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome
NCT02986750 ·Status: COMPLETED ·Phase: PHASE4
-
Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT
NCT06981104 ·Status: COMPLETED ·Phase: NA